BioXcel Therapeutics, Inc. (BTAI) Reports Q4 Loss, Tops Revenue Estimates

BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $3.57 per share versus the Zacks Consensus Estimate of a loss of$ 4.36. This compares to loss of $12.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.12%. A quarter ago, it was expected that this company would post a loss of$ 8 per share when it actually produced a loss of $5.12, delivering a surprise of 36%.Over the last four quarters, the company has su ...